首站-论文投稿智能助手
典型文献
Gout-associated monosodium urate crystal-induced necrosis is independent of NLRP3 activity but can be suppressed by combined inhibitors for multiple signaling pathways
文献摘要:
Monosodium urate(MSU)crystals,the etiological agent of gout,are formed in joints and periarticular tissues due to long-lasting hyperuricemia.Although MSU crystal-triggered NLRP3 inflammasome activation and interleukin 1β(IL-1β)release are known to have key roles in gouty arthritis,recent studies revealed that MSU crystal-induced necrosis also plays a critical role in this process.However,it remains unknown what forms of necrosis have been induced and whether combined cell death inhibitors can block such necrosis.Here,we showed that MSU crystal-induced necrosis in murine macrophages was not dependent on NLRP3 inflammasome activation,as neither genetic deletion nor pharmacological blockade of the NLRP3 pathway inhibited the necrosis.Although many cell death pathways(such as ferroptosis and pyroptosis)inhibitors or reactive oxygen species inhibitors did not have any suppressive effects,necroptosis pathway inhibitors GSK'872(RIPK3 inhibitor),and GW806742X(MLKL inhibitor)dose-dependently inhibited MSU crystal-induced necrosis.Moreover,a triple combination of GSK'872,GW806742X,and IDN-6556(pan-caspase inhibitor)displayed enhanced inhibition of the necrosis,which was further fortified by the addition of MCC950(NLRP3 inhibitor),suggesting that multiple cell death pathways might have been triggered by MSU crystals.Baicalin,a previously identified inhibitor of NLRP3,inhibited MSU crystal-induced inflammasome activation and suppressed the necrosis in macrophages.Besides,baicalin gavage significantly ameliorated MSU crystal-induced peritonitis in mice.Altogether,our data indicate that MSU crystals induce NLRP3-independent necrosis,which can be inhibited by combined inhibitors for multiple signaling pathways,highlighting a new avenue for the treatment of gouty arthritis.
文献关键词:
作者姓名:
Chun-su Zhong;Bo Zeng;Jia-hao Qiu;Li-hui Xu;Mei-yan Zhong;Yuan-ting Huang;Rong Xu;Si-ying Liu;Qing-bing Zha;Bo Hu;Dong-yun Ou-Yang;Xian-hui He
作者机构:
Department of Immunobiology,College of Life Science and Technology,Jinan University,Guangzhou 510632,China;Department of Cell Biology,College of Life Science and Technology,Jinan University,Guangzhou 510632,China;Department of Fetal Medicine,The First Affiliated Hospital of Jinan University,Guangzhou 510630,China;Department of Nephrology,The First Affiliated Hospital of Jinan University,Guangzhou 510630,China
引用格式:
[1]Chun-su Zhong;Bo Zeng;Jia-hao Qiu;Li-hui Xu;Mei-yan Zhong;Yuan-ting Huang;Rong Xu;Si-ying Liu;Qing-bing Zha;Bo Hu;Dong-yun Ou-Yang;Xian-hui He-.Gout-associated monosodium urate crystal-induced necrosis is independent of NLRP3 activity but can be suppressed by combined inhibitors for multiple signaling pathways)[J].中国药理学报(英文版),2022(05):1324-1336
A类:
Monosodium,GW806742X
B类:
Gout,associated,monosodium,urate,induced,necrosis,independent,NLRP3,activity,but,suppressed,by,combined,inhibitors,multiple,signaling,pathways,MSU,crystals,etiological,agent,are,formed,joints,periarticular,tissues,due,long,lasting,hyperuricemia,Although,triggered,inflammasome,activation,interleukin,release,have,key,roles,gouty,arthritis,recent,studies,revealed,that,also,plays,critical,this,process,However,remains,unknown,what,forms,been,whether,cell,death,such,Here,showed,murine,macrophages,was,not,neither,genetic,deletion,nor,pharmacological,blockade,inhibited,many,ferroptosis,pyroptosis,reactive,oxygen,species,did,suppressive,effects,necroptosis,GSK,RIPK3,MLKL,dose,dependently,Moreover,triple,combination,IDN,pan,caspase,displayed,enhanced,inhibition,which,further,fortified,addition,MCC950,suggesting,might,Baicalin,previously,identified,Besides,baicalin,gavage,significantly,ameliorated,peritonitis,mice,Altogether,our,data,indicate,highlighting,new,avenue,treatment
AB值:
0.509684
相似文献
Super-enhancer receives signals from the extracellular matrix to induce PD-L1-mediated immune evasion via integrin/ BRAF/TAK1/ERK/ETV4 signaling
Panpan Ma;Xinxin Jin;Zhiwei Fan;Zhou Wang;Suhui Yue;Changyue Wu;Shiyin Chen;Yuanyuan Wu;Miaomiao Chen;Donghua Gu;Siliang Zhang;Renfang Mao;Yihui Fan-Laboratory of Medical Science,School of Medicine,Nantong University,Nantong 226001,China;Department of Pathogenic Biology,School of Medicine,Nantong University,Nantong 226001,China;Department of Clinical Laboratory,Yancheng No.1 People's Hospital,Yancheng 224005,China;School of Life Sciences,Nantong University,Nantong 226001,China;Department of Dermatology,Affiliated Hospital of Nantong University,Nantong University,Nantong 226001,China;The Department of Urology,the Second Affiliated Hospital of Nantong University,Nantong University,Nantong 226001,China;The Department of Radiotherapy Oncology,Harbin Medical University Cancer Hospital,Harbin 150086,China;Department of Pathophysiology,School of Medicine,Nantong University,Nantong 226001,China
Taxifolin attenuates inflammation via suppressing MAPK signal pathway in vitro and in silico analysis
Xingyan Zhang;Xiaoyan Lian;Huling Li;Wenjing Zhao;Xin Li;Fujun Zhou;Yutong Zhou;Tao Cui;Yuli Wang;Changxiao Liu-Key Laboratory of Quality-marker of Traditional Chinese Medicines,Tianjin Institute of Pharmaceutical Research Co.,Ltd.,Tianjin 300462,China;Center for Drug Evaluation,National Medical Products Administration,Beijing 100022,China;Department of Pharmacology,Tianjin Medical University,Tianjin 300070,China;State Key Laboratory of Drug Delivery Technology and Pharmacokinetics,Tianjin Institute of Pharmaceutical Research Co.,Ltd.,Tianjin 300462,China;Key Laboratory of Systems Bioengineering(Ministry of Education),School of Chemistry Engineering and Technology,Tianjin University,Tianjin 300072,China;Pharmaceuticai Armaceuticai DA REN TANG Group Corporation Limited Traditional Chinese Pharmacy Researchinstitute,Tianjin 300457,China;Tianjin Key Laboratory of Quality Control in Chinese Medicine,Tianjin 300457,China;Research Unit for Drug Metabolism,Chinese Academy of Medical Sciences,Beijing 100730,China
Eupalinolide B inhibits hepatic carcinoma by inducing ferroptosis and ROS-ER-JNK pathway
Yonghui Zhang;Haoyang Zhang;Jinage Mu;Meiyue Han;Zhihao Cao;Feng Dong;Tingting Wang;Lian Pan;Wujing Luo;Jiaxin Li;Huan Liu;Lishan Jin;Wenxuan Ding;Yong Wei;Xuesong Deng;Dan Liu;Xiuzhen He;Yi Pang;Xiao Mu;Zhongjun Wu;Dilong Chen-The First Affiliated Hospital of Chongqing Medical University,Chongqing 400042,China;The People's Hospital Affiliated to Chongqing Three Gorges Medical College,Chongqing 404100,China;Chongqing Key Laboratory of Development and Utilization of Genuine Medicinal Materials in Three Gorges Reservoir Area,Chongqing 404120,China;Chongqing Engineering Research Center of Antitumor Natural Drugs,Chongqing 404120,China;Key Laboratory of Intelligent Information Processing and Control,College of Electronic and Information Engineering,Chongqing Three Gorges University,Chongqing 404110,China
A novel PI3K inhibitor XH30 suppresses orthotopic glioblastoma and brain metastasis in mice models
Ming Ji;Dongjie Wang;Songwen Lin;Chunyang Wang;Ling Li;Zhihui Zhang;Jing Jin;Deyu Wu;Yi Dong;Heng Xu;Duo Lu;Xiaoguang Chen-State Key Laboratory of Bioactive Substances and Functions of Natural Medicines,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China;Beijing Key Laboratory of Non-Clinical Drug Metabolism and PK/PD Study,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China;Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
Novel phthalimides regulating PD-1/PD-L1 interaction as potential immunotherapy agents
Chengliang Sun;Yao Cheng;Xiaojia Liu;Gefei Wang;Wenjian Min;Xiao Wang;Kai Yuan;Yi Hou;Jiaxing Li;Haolin Zhang;Haojie Dong;Liping Wang;Chenguang Lou;Yanze Sun;Xinmiao Yu;Hongbin Deng;Yibei Xiao;Peng Yang-State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization,China Pharmaceutical University,Nanjing 210009,China;Department of Medicinal Chemistry,School of Pharmacy,China Pharmaceutical University,Nanjing 211198,China;Department of Pharmacology,School of Pharmacy,China Pharmaceutical University,Nanjing 211198,China;Beijing Institute of Clinical Pharmacy,Beijing Friendship Hospital,Capital Medical University,Beijing 100050,China;Department of Physics,Chemistry and Pharmacy,University of Southern Denmark,Campusvej 55,5230 Odense,Denmark;Institute of Medicinal Biotechnology,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100050,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。